Comparison of pre-treatment with OCPs or estradiol valerate vs. no pre-treatment prior to GnRH antagonist used for IVF cycles: An RCT

Comparison of pre-treatment with OCPs or estradiol valerate vs. no pre-treatment prior to GnRH antagonist used for IVF cycles: An RCT

Background: Both oral contraceptive pills (OCPs) and estradiol valerate (E2) have been used to schedule a gonadotropin-releasing hormone antagonist in vitro fertilization (IVF) cycles. Since the suppression of follicle-stimulating hormone by OCPs can stay 5-7 days after stopping the pills, it seems...

Full description

Saved in:
Bibliographic Details
Main Authors: Ensieh Shahrokh Tehrani Nejad (Author), Fatemeh Bakhtiari Ghaleh (Author), Bita Eslami (Author), Fedyeh Haghollahi (Author), Maryam Bagheri (Author), Masoumeh Masoumi (Author)
Format: Book
Published: Shahid Sadoughi University of Medical Sciences, 2018-08-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items